Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven J Cohen
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
232 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- the Medical Center of Aurora
Aurora, Colorado, United States
- Boulder Community Foothills Hospital
Boulder, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Adventhealth Porter
Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- Saint Joseph Hospital - Cancer Centers of Colorado
Denver, Colorado, United States
- Western States Cancer Research Ncorp
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- Saint Mary'S Hospital and Regional Medical Center
Grand Junction, Colorado, United States
- Banner North Colorado Medical Center
Greeley, Colorado, United States
- Commonspirit Saint Anthony Hospital Cancer Center
Lakewood, Colorado, United States
- Adventhealth Littleton
Littleton, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Longmont United Hospital
Longmont, Colorado, United States
- Banner North Colorado Medical Center - Loveland Campus
Loveland, Colorado, United States
- Adventhealth Parker
Parker, Colorado, United States
- Saint Mary Corwin Medical Center
Pueblo, Colorado, United States
- North Suburban Medical Center
Thornton, Colorado, United States
- Intermountain Health Lutheran Hospital
Wheat Ridge, Colorado, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Lewis Cancer and Research Pavilion at Saint Joseph'S/candler
Savannah, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Rush-Copley Medical Center
Aurora, Illinois, United States
- Macneal Hospital and Cancer Center
Berwyn, Illinois, United States
- Osf Saint Joseph Medical Center
Bloomington, Illinois, United States
- Graham Hospital Association
Canton, Illinois, United States
- Memorial Hospital
Carthage, Illinois, United States
- Hematology and Oncology Associates
Chicago, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Heartland Cancer Research Ncorp
Decatur, Illinois, United States
- Eureka Hospital
Eureka, Illinois, United States
- Illinois Cancercare-Galesburg
Galesburg, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Sept 2010
- Primary completion
- 15 Jul 2014
- Completion
- 31 Mar 2027
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 94
- Registry id
- NCT01142388
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.